发明名称 |
Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia |
摘要 |
The present disclosure provides an extended release pharmaceutical composition comprising hydrocodone and acetaminophen that provides a rapid onset of analgesia, and reduced levels of acetaminophen near the end of the dosing interval. Also provided are methods for reducing the risk of acetaminophen-induced hepatic damage in a subject being treated with an acetaminophen containing composition, as well as methods for treating pain in a subject in need thereof. |
申请公布号 |
US9539328(B2) |
申请公布日期 |
2017.01.10 |
申请号 |
US201414479129 |
申请日期 |
2014.09.05 |
申请人 |
MALLINCKRODT LLC |
发明人 |
Devarakonda Krishna;Giuliani Michael J.;Gupta Vishal K.;Heasley Ralph A.;Shelby Susan |
分类号 |
A61K9/20;A61K47/10;A61K51/12;A61K9/24;A61K31/167;A61K31/485 |
主分类号 |
A61K9/20 |
代理机构 |
Mayer Brown LLP |
代理人 |
Mayer Brown LLP |
主权项 |
1. An extended release pharmaceutical composition, comprising:
an immediate release portion comprising hydrocodone or a pharmaceutically acceptable salt of hydrocodone, acetaminophen, or a combination thereof; and an extended release portion comprising hydrocodone or a pharmaceutically acceptable salt of hydrocodone, acetaminophen, or a combination thereof; wherein the total amount of acetaminophen in the composition is from about 325 mg to about 650 mg and the total amount of hydrocodone or a pharmaceutically acceptable salt thereof in the composition is from about 7.5 mg to about 15 mg; wherein when the composition is orally administered to a subject in need thereof the composition delivers the hydrocodone or the pharmaceutically acceptable salt thereof and the acetaminophen to the subject's upper gastrointestinal tract for at least about 4 hours to about 12 hours; and wherein there is substantially no effect on AUC0-inf for hydrocodone and acetaminophen when the pharmaceutical composition is administered in a fed versus fasted state. |
地址 |
Hazelwood MO US |